Pulse Explorer nav.journalClub Débats Tendances Chercheurs Revues

Accueil Explorer nav.journalClub Tendances

⌘+K

Interleukin 6 drives durable T cell-mediated immunity to pancreatic cancer | Synapse

March 21, 2026Cellular and Molecular Gastroenterology and Hepatology0 citationsOpen Access

Interleukin 6 drives durable T cell-mediated immunity to pancreatic cancer

View Full Paper

PAPaige C. Arneson-Wissink ABAlexandra Q. Bartlett HMHeike Mendez

Key Points

This research aims to explore the role of interleukin 6 in enhancing T cell responses against pancreatic cancer.
Assessment of IL-6 concentrations in tumor microenvironments
Evaluation of T cell anti-tumor responses
Comparison of PDAC responses with varying IL-6 levels
High IL-6 levels correlate with stronger T cell-mediated responses against pancreatic tumors
Enhanced tumor control observed in the presence of elevated IL-6 concentrations

Abstract

Locally high IL-6 concentrations potently enhance the T cell-mediated anti-tumor response to PDAC.

Demander à l'IA

Like

Bookmark

Share

View Full Paper

Demander à l'IA

Like

Bookmark

Share

View Full Paper

Cite This Study

Arneson-Wissink et al. (Sun,) studied this question.

synapsesocial.com/papers/69be35166e48c4981c67336e https://doi.org/https://doi.org/10.1016/j.jcmgh.2026.101768